In addition, no differences were observed between genotypes regarding Timp3 levels (TACE inhibitor) in healthy controls and chronic DSS-induced colitis groups and decreased expression of Timp3 was detected after chronic colitis induction in both genotypes (Fig. 2c). This evidence concerns the gene ADAM17 and colitis.